MONO AND BISPECIFIC ANTIBODIES FOR EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III AND CD3 AND THEIR USES - Patent 3405490

(19)

(11)

EP 3 405 490 A1

(12)

(43)	Date of publication:
	28.11.2018 Bulletin 2018/48

(21)	Application number: 17700749.9

(22)	Date of filing: 10.01.2017

(51)

International Patent Classification (IPC):

C07K 16/28^(2006.01)
A61P 35/00^(2006.01)

C07K 16/30^(2006.01)

(86)	International application number:
	PCT/IB2017/050109

(87)	International publication number:
	WO 2017/125831 (27.07.2017 Gazette 2017/30)

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
	Designated Extension States:
	BA ME
	Designated Validation States:
	MA MD

(30)

Priority:

21.01.2016 US 201662281543 P
08.12.2016 US 201662431766 P

(71)	Applicant: Pfizer Inc.
	New York, NY 10017 (US)

(72)	Inventors:
	CHOU, Joyce Ching Sunnyvale, CA 94086 (US) WONG, Oi Kwan Belmont, CA 94002 (US)

(74)	Representative: Cooley (UK) LLP
	Dashwood 69 Old Broad Street London EC2M 1QS London EC2M 1QS (GB)

(54)	MONO AND BISPECIFIC ANTIBODIES FOR EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III AND CD3 AND THEIR USES